Primary tabs

ADS-4101

New Formulations and Indications
  • PRE
  • P1
  • P2
  • P3
Sponsors / Collaborators Adamas Pharmaceuticals, Epilepsy Foundation (EF)
Mechanism of Action New Formulation
: Voltage Gated Sodium Channels (modified release of lacosamide)
Populations Tested In Focal Seizures
Special FDA Designation
  • N/A
Nonprofit / Government Support Nonprofit
: Epilepsy Foundation - Investment
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc) AEDD XV - 2019
Location of Clinical Trials N/A
Clinical Trial Link

Our Mission

The mission of the Epilepsy Foundation is to lead the fight to overcome the challenges of living with epilepsy and to accelerate therapies to stop seizures, find cures, and save lives.

 
24/7 helpline
P